A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

NCT00396955 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

560

Enrollment

INDUSTRY

Sponsor class

Stopped imbalance of gastrointestinal and the lipase events

Conditions

Osteoarthritis

Interventions

DRUG: PLA-695

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer